Medicine and Dentistry
Diabetes
100%
Maturity Onset Diabetes of the Young
88%
Cost-Effectiveness Analysis
88%
Bone Density
71%
Burosumab
66%
Osteolysis
59%
Health Care Cost
55%
Treatment Group
46%
Carotid Endarterectomy
44%
Congestive Heart Failure
44%
Nutrition Supplement
44%
Osteoporosis
44%
Systematic Review
44%
Dermatomyositis
44%
Premenopause
44%
Tattoo
44%
Breast Cancer
44%
Randomized Controlled Trial
44%
Calcinosis Cutis
44%
Hemoglobin A1c
33%
X Linked Hypophosphatemic Rickets
31%
Underserved Population
30%
Diseases
29%
Nutrition
29%
Clinical Endocrinology
22%
Phosphate Metabolism
22%
Fragility Fracture
22%
Anabolic Agent
22%
Acid-Base Imbalance
22%
Calcium Sensing Receptor
22%
Parathyroid Disease
22%
Parathyroid Hormone Release
22%
Calcium Balance
22%
Monoclonal Antibody
22%
Hypophosphatemia
22%
Fibroblast Growth Factor 23
22%
Endocrinology
22%
Lumbar Spine
17%
Diabetes Mellitus
16%
Human Study
14%
Molecular Research
14%
Effect Size
14%
Fracture
14%
Bone Mass
14%
National Health Service
14%
Vitamin D
14%
Supplementation
14%
Isoflavone Derivative
14%
Dietary Intake
14%
Isotopes of Calcium
14%
Keyphrases
Hyperparathyroid
44%
Heart Failure
44%
Fracture Liaison Service
44%
Hypophosphatemic Rickets
44%
Comprehensive Cost
44%
Uncontrolled Type 2 Diabetes
44%
Secondary Fracture Prevention
44%
Type 2 Diabetes Mellitus (T2DM)
44%
Burosumab
44%
Arterialized
44%
Cutaneous Skeletal Hypophosphatemia Syndrome
44%
Stage-based
44%
Low Bone Mineral Density
44%
Plasma Phosphate
22%
Calcium-sensing Receptor (CaSR)
22%
2D Growth
22%
Drug Class
22%
Metabolic Therapy
22%
Management Strategy
22%
Cardiovascular Outcomes
22%
Diabetes Management
22%
CHEERS
22%
Parathyroid Disease
22%
Heart Failure Outcomes
22%
Calcium Balance
22%
Glycemic Control
22%
Insulin Resistance
22%
Mechanistic Role
22%
Heart Failure Stages
22%
Cell Substrate
22%
Dyslipidemia
22%
Substrate Metabolism
22%
Central Obesity
22%
Indirect Action
14%
Blood Pressure Rhythm
14%
Heart Rhythm
14%
Cardiovascular Parameters
14%
Nutrient Supplements
14%
Nutrient Intervention
14%
Maternal Intake
14%
Uncontrolled Diabetes
14%
Federally Qualified Health Center
14%
Regression Discontinuity Design
14%
Policy Forum
14%
Quasi-experimental Methods
14%
Evidence-based Policy
14%
X-linked Hypophosphatemia
12%
Tumor-induced Osteomalacia
12%
Human Burden
11%
Cost Categories
11%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
88%
Cost Effectiveness Analysis
88%
Treatment Group
55%
Systematic Review
44%
Congestive Heart Failure
44%
Breast Cancer
44%
Underserved Population
36%
Practice Guideline
36%
Treatment Outcome
33%
Hemoglobin A1c
33%
Bone Density
33%
Institutional Review
22%
Diabetes Mellitus
17%
Socialized Medicine
14%
Cost Control
11%
Muscle Mass
11%
Patient Coding
11%
Student T Test
11%
Hospital
11%
Dual Energy X Ray Absorptiometry
11%
Glycosylated Hemoglobin
11%
Prevalence
11%
Health Center
11%
Cancer Therapy
11%
Patient with Diabetes
11%
Obesity
11%
Health Care Policy
11%
Bone Turnover
11%
Insulin Resistance
11%
Dyslipidemia
11%
General Practitioner
11%
Adjuvant Chemotherapy
11%
Endocrinologist
11%
Cancer Diagnosis
11%
Internal Validity
6%
Economic Evaluation
6%
Incremental Cost-Effectiveness Ratio
6%
Health Care Access
6%
Prescription Drug
6%